Jason Layt
I recently availed of their services and I must say I am impressed. The company's professionalism is top-notch, and their attention to detail is commendable. I'm glad I chose them.
Ask AI about Cytoguide
AI-generated from reviews on this page. Verify anything important with the company directly.
Barbara Lerner
I recently used their services and I'm quite happy with the outcome. They were efficient, professional, and timely in delivering the results I expected. Would definitely recommend them.
Bridgette Gordon
Cytoguide has been an exceptional company to work with. Their services are prompt, reliable, and of the highest quality. Their team is friendly and helpful. Keep up the great work!
Ruby Kelley
I have been using Cytoguide's services for some time now and I couldn't be happier. Their professionalism and attention to detail are commendable. Highly satisfied with their services.
Haziq Wahid
Cytoguide has been my go-to company for all my needs. Their services are exceptional, and their dedication to customer satisfaction is commendable. The prices are reasonable too. Highly recommended!
Pablo Barcos
Cytoguide is an average company. Their services are satisfactory, but nothing extraordinary. I wouldn't say I had a great experience, but it wasn't terrible either. Overall, it's an okay company to work with.
Leonard Ebel
👏 Cytoguide is a company that exceeded my expectations. Their services are outstanding and their team is incredibly knowledgeable. I am genuinely impressed and would highly recommend them.
Kody Tinnel
😊 Cytoguide is an excellent company! I am impressed with their high-quality services and exceptional customer support. They have a user-friendly website and offer competitive prices. 👍
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Cytoguide
Cytoguide is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and registered drugs with known pharmacological effects to targeting receptor-binding protein partners. The development of receptor-targeted therapeutics will focus on the macrophage specific receptor CD163, the most abundant transport receptor on macrophages. The company has the IP right for existing CD163 targeting technology as well as strong scientific experience and know-how to exploit the use of this receptor for drug therapy. The combined drugs are aimed to improve the treatment of monocyte/macrophage-related diseases including autoimmune disease, leukemia and infectious diseases.
- Website
- cytoguide.dk
- jhg@cytoguide.dk